COPD and Asthma Devices Global Market Report 2023: Sector to Reach $60.4 Billion by 2028 at a 5.66% CAGR
DUBLIN, March 27, 2023 /PRNewswire/ -- The "COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global COPD and asthma devices market size reached US$ 43.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 60.4 Billion by 2028, exhibiting a CAGR of 5.66% during 2022-2028.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness.
On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.
COPD and Asthma Devices Market Trends:
The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices.
Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth.
The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome.
Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.
Key Market Segmentation:
Breakup by Product:
- Drug Powdered Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Soft Mist Inhalers
- Compressor Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Breakup by Indication:
Breakup by Distribution Channel:
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America
- United States
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
5 Global COPD and Asthma Devices Market
6 Market Breakup by Product
7 Market Breakup by Indication
8 Market Breakup by Distribution Channel
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
- Adherium Limited
- Aristopharma Ltd.
- AstraZeneca PLC
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- Cohero Health Inc.
- Koninklijke Philips N.V.
- Omron Corporation
- Pari Respiratory Equipment Inc.
- Recipharm AB
- Verona Pharma plc.
For more information about this report visit https://www.researchandmarkets.com/r/ayfkrk
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/copd-and-asthma-devices-global-market-report-2023-sector-to-reach-60-4-billion-by-2028-at-a-5-66-cagr-301782328.html
SOURCE Research and Markets
Upcoming Life Sciences Events
- June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston
Latest company news
Multicancer Screening Global Market Report 2023: Sector to Reach $7.78 Billion by 2032 at a 15% CAGR
Haleon's Panadol Klinik Cekatan extends reach to people with limited mobility and healthcare access in areas affected by natural disasters
Lung Cancer Therapies Market to Amplify Significantly over 2022-2029 - Brandessence Market Research